ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00096954
Brief Title: A Prospective, Randomized, Double-Blind Study of the Efficacy of Omalizumab (Xolair) in Atopic Asthmatics With Good Lung Capacity Who Remain Difficult to Treat (EXACT) (EXACT)

First Submitted : November 17, 2004
First Submitted that Met QC Criteria : November 17, 2004
First Posted : November 18, 2004 (Estimate)

Results First Submitted : August 8, 2011
Results First Submitted that Met QC Criteria : November 3, 2011
Results First Posted : December 8, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : May 16, 2017
Last Update Posted : June 14, 2017